WASHINGTON, United States (AFP) — An anti-diabetic drug that lowers blood sugar levels for type 2 diabetes sufferers also significantly cuts the risk of cardiovascular and kidney disease, according to a study published Monday. The findings, published in the New England Journal of Medicine, came in a clinical trial of more than 10,000 patients in 30 countries, using canagliflozin. It found the drug reduced the overall risk of cardiovascular disease by 14 percent and reduced […]